- Details
- Men who undergo surgery as definitive therapy for their localized prostate cancer generally only receive subsequent radiation therapy if their surgical pathology shows high-risk adverse pathologic features (adjuvant radiotherapy) or if they experience biochemical recurrence (salvage radiotherapy). Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/A...
|
- Details
- Samir Taneja joins a panel of urologists to debate the use of ultrasound when compared to magnetic resonance imaging (MRI) as the best diagnostic and guidance imaging option for prostate cancer patients. Prostate ultrasound, specifically, micro-ultrasound, has a high sensitivity for predicting clinically significant cancer however its diagnostic accuracy is dependent on the urologist performing th...
|
- Details
- In this Journal Club, Zachary Klaassen discusses a study on surgeon age with Raj Satkunasivam and Chris Wallis each an author on the paper titled, "Relationship Between Surgeon Age and Postoperative Outcomes, A Population-Based Cohort Study,” published in the Canadian Medical Association Journal. The surgical workforce, especially for urologists, is aging. This study aimed to determine whether pos...
|
- Details
- Continence Nurse Practitioner and Biofeedback-Certified Specialist, Diane Newman presents Urinary Symptoms Post-Prostatectomy Case Study of a 68-year old male with long-term lower urinary tract symptoms, treated for many years for BPH who had a robotic-assisted radical prostatectomy after being diagnosed with prostate cancer. Biographies: Diane K. Newman, DNP, ANP-BC, FAAN , Adjunct Professor of U...
|
- Details
- Continence Nurse Practitioner and Biofeedback-Certified Specialist, Diane Newman presents on one of the most challenging complications and an independent predictor of global quality of life, post-prostatectomy incontinence. Biographies: Diane K. Newman, DNP, ANP-BC, FAAN , Adjunct Professor of Urology in Surgery, Perelman School of Medicine, University of Pennsylvania and Co-Director of the Penn C...
|
- Details
- John Feller presents at the Focal Therapy and Imaging in Prostate and Kidney Cancer Symposium, sharing interim 10-year results of the Phase II trial of Laser Focal Therapy for prostate cancer. This involves an outpatient trans-rectal laser therapy guided with an MRI imaging system. 95% of patients were biopsy compliant at 6 months and 94% avoided whole gland therapy and associated morbidity. The r...
|
- Details
- Prostate cancer survivor John Fortin is joined by Art Rastinehad a professor of urology and radiology at Mount Sinai to discuss targeted therapies for prostate cancer. Together they discuss when patients are recommended to active surveillance, versus when they must receive more complex treatment regimes. They discuss the research done to identify and test focal therapies for prostate cancer. Dr. R...
|
- Details
- Tom Polascik, a urologic oncologist with considerable experience in treating both kidney and prostate cancer and the founder of the Focal Therapy Society joins John Fortin providing a background of the Focal Therapy society and the 12th International Symposium on focal therapy and imaging in prostate and kidney cancer. He shares the concept of the society and summarizes the evolution of care in pr...
|
- Details
- Matthew Allaway, CEO of Corbin Clinical Resources, surveys the relative benefits of transperineal versus transrectal prostate biopsy. Although transrectal ultrasound-guided prostate biopsy has been the standard for prostate cancer diagnosis since the 1980s, recent studies have revisited the transperineal approach due to the incidence of infectious and sepsis complications and missed cancer diagnos...
|
- Details
- Lorelei Mucci and Elizabeth Platz join Charles Ryan in a discussion on the impact of vitamin D and statins on prostate cancer outcomes. There is no direct evidence linking vitamin D and the risk of prostate cancer, however, vitamin D is believed to be important for overall good health. There is an inverse relationship between cholesterol and risk for the development of prostate cancer and statin u...
|
